. This study is an attempt to produce a fusion protein by binding the fragment NT-gp96 in upstream of sequence of the N terminal fragment (NT300) of the NS5B gene in an expression vector.
Amir Atapour
Advertisement
Amir Atapour is a PhD student at Department of Medical Biotechnology, School of Advanced Medical Science and Technologies, Shiraz University of Medical Sciences, Iran.
Articles by Amir Atapour
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Amgen Real-World Study Links Evolocumab to Lower Heart Attack Risk Than Ezetimibe
2
T-Therapeutics Raises $133 Million to Take TCR Bispecifics Into the Clinic
3
Alethio Raises $90 Million to Advance First-in-Class G6B Antibody for Essential Thrombocythemia
4
VeonGen Aligns with FDA on Phase 3 Design for Stargardt Gene Therapy
5